Stay updated with breaking news from Highly Specialised Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON - Rhythm Pharmaceuticals, Inc. , a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases,...
IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centresBOSTON, May 22, 2024 -- Rhythm...
IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centresBOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals
A mother has been left devastated by a government ruling set to take away a 'miracle drug' that has stopped her motor neurone disease from progressing.
- IMCIVREE will be funded and available for use within 90 days in the National Health Service - BOSTON, July 18, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage